Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use
Rossing P, Agarwal R, Anker AS, et al.
Diabetes Obes Metab. 2023;25(2):407-16.
Leggi
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Rossing P, Agarwal R, Anker AS, et al.
Diabetes Obes Metab. 2023;25(2):407-16.
Leggi
Beck RW, Raghinaru D, Calhoun P, Bergenstal MR
Diabetes Technol Ther. Pub. online 28 Dec 2022.
Leggi
Raitakari O, Kartiosuo N, Pahkala K, et al.
Circulation. 2023;147(1):23-31.
Leggi
Moody AJ, Molina-Wilkins M, Clarke GD, et al.
Diabetes Obes Metab. 2023;25(2):426-34.
Leggi
Yamaguchi S, Shimabukuro M, Tanaka A, et al.
Diabetes Obes Metab. 2023;25(2):354-64.
Leggi
Weghuber D, Barrett T, Barrientos-Pérez M, et al.
N Engl J Med. 2022;387:2245-2257.
Leggi
Lee YJ, Cho JY, You SC, et al.
European Heart Journal. ehac709.
Leggi
Marx N, Husain M, Lehrke M, et al.
Circulation. 2022;146:1882-1894.
Leggi
Pulkkinen MA, Varimo T, Hakonen ET, et al.
Diabetes Technol Ther. Pub. online 13 Dec 2022.
Leggi
Lazzarini PA, Cramb SM, Golledge J, et al.
Diabetologia. Pub. online 13 Dec 2022.
Leggi